{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:39:02Z","timestamp":1761323942653},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T00:00:00Z","timestamp":1400025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s11255-014-0724-z","type":"journal-article","created":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T12:51:46Z","timestamp":1399985506000},"page":"1809-1813","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Combination therapy with low-dose metolazone and furosemide: a \u201cneedleless\u201d approach in managing refractory fluid overload in elderly renal failure patients under palliative care"],"prefix":"10.1007","volume":"46","author":[{"given":"Hon Wai Benjamin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mau-Kwong","family":"Sham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok-Ying","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cho-Wing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Yan","family":"Au","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence","family":"Yip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,14]]},"reference":[{"issue":"2","key":"724_CR1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/jpm.2011.0207","volume":"15","author":"NR O\u2019Connor","year":"2012","unstructured":"O\u2019Connor NR, Kumar P (2012) Conservative management of end-stage renal disease without dialysis: a systematic review. J Palliat Med 15(2):228\u2013235","journal-title":"J Palliat Med"},{"key":"724_CR2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/0269216306070236","volume":"20","author":"T Saini","year":"2006","unstructured":"Saini T, Murtagh FE, Dupont PJ et al (2006) Comparative pilot study of symptoms and quality of life in cancer patients and patients with end stage renal disease. Palliat Med 20:631\u2013636","journal-title":"Palliat Med"},{"key":"724_CR3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jpainsymman.2010.01.021","volume":"40","author":"FE Murtagh","year":"2010","unstructured":"Murtagh FE, Addington-Hall J, Edmonds P et al (2010) Symptoms in the month before death for stage 5 chronic kidney disease patients managed without dialysis. J Pain Symptom Manage 40:342\u2013352","journal-title":"J Pain Symptom Manage"},{"key":"724_CR4","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1089\/jpm.2007.0017","volume":"10","author":"FE Murtagh","year":"2007","unstructured":"Murtagh FE, Addington-Hall J, Edmonds P et al (2007) Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J Palliat Med 10:1266\u20131276","journal-title":"J Palliat Med"},{"issue":"4","key":"724_CR5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10557-005-3350-2","volume":"19","author":"J Rosenberg","year":"2005","unstructured":"Rosenberg J, Gustafsson F, Galatius S, Hildebrandt PR (2005) Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature. Cardiovasc Drugs Ther 19(4):301\u2013306","journal-title":"Cardiovasc Drugs Ther"},{"key":"724_CR6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/clc.4960231211","volume":"23","author":"TM Ramahi","year":"2000","unstructured":"Ramahi TM, Longo MD, Rohlfs K, Sheynberg N (2000) Effect of heart failure program on cardiovascular drug utilization and dosage in patients with chronic heart failure. Clin Cardiol 23:909\u2013914","journal-title":"Clin Cardiol"},{"issue":"5834","key":"724_CR7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/bmj.4.5834.196","volume":"4","author":"HJ Dargie","year":"1972","unstructured":"Dargie HJ, Allison ME, Kennedy AC, Gray MJ (1972) High dosage metolazone in chronic renal failure. BMJ 4(5834):196\u2013198","journal-title":"BMJ"},{"key":"724_CR8","doi-asserted-by":"crossref","unstructured":"Galla JH (2000) Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis. The Renal Physicians Association and the American Society of Nephrology. J Am Soc Nephrol 11(7):1340\u20131342","DOI":"10.1681\/ASN.V1171340"},{"key":"724_CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0269216308101099","volume":"23","author":"DS Yong","year":"2009","unstructured":"Yong DS, Kwok AO, Wong DM et al (2009) Symptom burden and quality of life in end-stage renal disease: a study of 179 patients on dialysis and palliative care. Palliat Med 23:111\u2013119","journal-title":"Palliat Med"},{"issue":"8","key":"724_CR10","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1089\/jpm.2012.0504","volume":"16","author":"KY Chan","year":"2013","unstructured":"Chan KY, Li CW, Wong H et al (2013) Use of sertraline for antihistamine-refractory uremic pruritus in renal palliative care patients. J Palliat Med 16(8):966\u2013970","journal-title":"J Palliat Med"},{"key":"724_CR11","doi-asserted-by":"crossref","unstructured":"Cheng BHW, Sham MMK, Chan KY et al. (2013) Intensive palliative care for patients with hematological cancer dying in hospice: analysis of the level of medical care in the final week of life. Am J Hosp Palliat Care [Epub ahead of Print]. doi: 10.1177\/1049909113512412","DOI":"10.1177\/1049909113512412"},{"issue":"5","key":"724_CR12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/PPO.0b013e3181f842b3","volume":"16","author":"F Strasser","year":"2010","unstructured":"Strasser F, Blum D, Bueche D (2010) Invasive palliative interventions: when are they worth it and when are they not? Cancer J 16(5):483\u2013487","journal-title":"Cancer J"},{"key":"724_CR13","first-page":"276","volume":"29","author":"ON Hinsvark","year":"1970","unstructured":"Hinsvark ON, Cohen AI (1970) The study of metolazone, a new diuretic, in human body fluids using thin layer separation, liquid chromatographic measurements and14C-counting techniques. Fed Proc 29:276 (Abstract)","journal-title":"Fed Proc"},{"key":"724_CR14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/cpt1974162322","volume":"16","author":"WJ Tilstone","year":"1974","unstructured":"Tilstone WJ, Dargie H, Dargie EN, Morgan HG, Kennedy AC (1974) Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure. Clin Pharmacol Ther 16:322\u2013329","journal-title":"Clin Pharmacol Ther"},{"key":"724_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0002-8703(75)90041-1","volume":"89","author":"B Sigurd","year":"1975","unstructured":"Sigurd B, Olesen KH, Wennevold A (1975) The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide. Am Heart J 89:163\u2013170","journal-title":"Am Heart J"},{"issue":"4","key":"724_CR16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/1074248413482755","volume":"18","author":"TM Ng","year":"2013","unstructured":"Ng TM, Konopka E, Hyderi AF et al (2013) Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure. J Cardiovasc Pharmacol Ther 18(4):345\u2013353","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"6","key":"724_CR17","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/0269216311399490","volume":"25","author":"H Zacharias","year":"2011","unstructured":"Zacharias H, Raw J, Nunn A, Parsons S, Johnson M (2011) Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure? Palliat Med 25(6):658\u2013663","journal-title":"Palliat Med"},{"issue":"8","key":"724_CR18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/1049909112465795","volume":"30","author":"LB Farless","year":"2013","unstructured":"Farless LB, Steil N, Williams BR, Bailey FA (2013) Intermittent subcutaneous furosemide: parenteral diuretic rescue for hospice patients with congestive heart failure resistant to oral diuretic. Am J Hosp Palliat Care 30(8):791\u2013792","journal-title":"Am J Hosp Palliat Care"},{"issue":"6","key":"724_CR19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4037\/ajcc2009938","volume":"18","author":"EH Elpern","year":"2009","unstructured":"Elpern EH, Killeen K, Ketchem A et al (2009) Reducing use of indwelling urinary catheters and associated urinary tract infections. Am J Crit Care 18(6):535\u2013541","journal-title":"Am J Crit Care"},{"issue":"7","key":"724_CR20","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1046\/j.1365-2389.2003.51330.x","volume":"51","author":"EJ Lamb","year":"2003","unstructured":"Lamb EJ, Webb MC, Simpson DE et al (2003) Estimation of glomerular filtration rate in older patients with chronic renal insufficiency: is the modification of diet in renal disease formula an improvement? J Am Geriatr Soc 51(7):1012\u20131017","journal-title":"J Am Geriatr Soc"},{"key":"724_CR21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jgs.12760","volume":"62","author":"HWB Cheng","year":"2014","unstructured":"Cheng HWB, Li CW, Chan KY et al (2014) Bringing palliative care into geriatrics in a chinese culture society\u2014results of a collaborative model between palliative medicine and geriatrics unit in Hong Kong. J Am Geriatr Soc 62:779\u2013781. doi: 10.1111\/jgs.12760","journal-title":"J Am Geriatr Soc"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-014-0724-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-014-0724-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-014-0724-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T13:44:28Z","timestamp":1648993468000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-014-0724-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,14]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["724"],"URL":"https:\/\/doi.org\/10.1007\/s11255-014-0724-z","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,14]]}}}